These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26259653)

  • 21. miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.
    Li X; Jiang H; Xiao L; Wang S; Zheng J
    Med Sci Monit; 2017 Feb; 23():1001-1008. PubMed ID: 28234890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27.
    Hu XH; Zhao ZX; Dai J; Geng DC; Xu YZ
    J Cell Biochem; 2019 Mar; 120(3):4665-4674. PubMed ID: 30582227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/EMT pathway.
    Lv DB; Zhang JY; Gao K; Yu ZH; Sheng WC; Yang G; Gao YZ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4618-4628. PubMed ID: 31210288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
    Han C; Wang W
    Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
    Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
    J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
    He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
    DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.
    Chen G; Fang T; Huang Z; Qi Y; Du S; Di T; Lei Z; Zhang X; Yan W
    Cell Physiol Biochem; 2016; 38(2):598-608. PubMed ID: 26845446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
    Sun XH; Geng XL; Zhang J; Zhang C
    Tumour Biol; 2015 Mar; 36(3):2127-34. PubMed ID: 25403884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/β-catenin Signaling in Vitro.
    Yu M; Guo D; Cao Z; Xiao L; Wang G
    Cancer Invest; 2018 Mar; 36(3):175-184. PubMed ID: 29565702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
    Zhang Q; Yin X; Zhang Y
    Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-1247 inhibits the viability and metastasis of osteosarcoma cells via targeting NRP1 and mediating Wnt/β-catenin pathway.
    Wei QF; Yao JS; Yang YT
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7266-7274. PubMed ID: 31539113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.